arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Disc Medicine, Inc.

IRON

$77.45 ▼ -0.11 (-0.14%) at close

27 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Moderately Bearish

auto_awesome

Analytical Summary

Disc Medicine, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $3.0B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -9.3% ↗

FCF / Share $-1.14 ↗

Trailing P/E —

Price / Book 4.6x

FCF Yield —

Debt / Equity 0.09

info Valuation on last close. End-of-day price, Aug 7, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-63.50M

↓ -86.3% —

FCF / Share Free cash flow per share

$-1.14

↑ +29.3% —

Long-Term Debt Long-term obligations

$59.34M

↑ +102.1% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	2.5% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-61.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-65.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-98.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-53.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	6.4% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-1.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-53.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-39.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	9.2% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	86.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-625.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-362.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	81.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	81.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	57.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-86.3% Weak ↓ Weak Declining Year-over-year change in net income	-86.3% Weak ↓ Weak Declining Year-over-year change in net income	-105.5% Weak ↓ Weak Declining Year-over-year change in net income	-26.5% Weak → Weak Stable Year-over-year change in net income	-26.5% Weak ↓ Weak Declining Year-over-year change in net income	-26.5% Weak ↓ Weak Declining Year-over-year change in net income	-24.9% Weak ↓ Weak Declining Year-over-year change in net income	-18.3% Weak ↑ Weak Improving Year-over-year change in net income	-18.3% Weak ↑ Weak Improving Year-over-year change in net income	-18.3% Weak ↑ Weak Improving Year-over-year change in net income	-109.7% Weak ↓ Weak Declining Year-over-year change in net income	-49.6% Weak → Weak Stable Year-over-year change in net income	-49.6% Weak ↓ Weak Declining Year-over-year change in net income	-49.6% Weak ↓ Weak Declining Year-over-year change in net income	N/M	20.0% Good → Good Stable Year-over-year change in net income	20.0% Good ↑ Good Improving Year-over-year change in net income	20.0% Good ↑ Good Improving Year-over-year change in net income	N/M	-95.4% Weak → Weak Stable Year-over-year change in net income	-95.4% Weak Weak Year-over-year change in net income	-95.4% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	-27.6% Weak Weak Year-over-year change in free cash flow	—	—	—	6.6% Fair Fair Year-over-year change in free cash flow	—	—	—	27.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Effective Tax Rate (%) (%)	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.70x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.40x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.24x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.25x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.56x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-9.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-11.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-25.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	98.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	75.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	79.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-76084.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-8.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-8.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-6.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-5.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-3.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	22.0% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—	-8.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-117.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-9.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-9.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	-8.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-5.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	-5.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-5.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-6.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-144%)	-5.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-5.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-8.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-6.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-6.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-142%)	-6.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-9.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-6.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-142%)	-14.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-197%)	-14.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-13.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-28.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-288%)	-13.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-190%)	-12.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-181%)	-11.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	65.5% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+337%)	117.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+685%)	147.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+882%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	0.09x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-85%)	0.04x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.04x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.05x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.05x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.04x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.06x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-89%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.64x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-207%)	—	—	—	—
Interest Coverage (x)	-99.96x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-108.63x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-98.63x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-95.48x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-57.23x Weak Weak Operating income divided by interest expense Optimal: > 5x	-174.49x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	-91.15x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-150.71x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-229.95x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-177.40x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-134.88x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.92x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.17x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-62.30x Weak Weak Operating income divided by interest expense Optimal: > 5x	-62.95x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-39.34M	$-59.55M	$-61.99M	$-111.72M	$-98.60M	$-94.15M	$-164.11M	$-192.64M	$-280.66M	$-342.62M	—	$-370.54M	$-377.60M	$-236.42M	$-194.61M	$-101.74M	$-108.66M	$-119.06M	$-88.04M	—	—	$-184.99M	$9.50M	—	—	—	—
Debt / EBITDA (x)	-0.91x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.42x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.44x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.43x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.47x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.71x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.82x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-1.44x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-1.54	$-1.65	$-1.62	$-1.77	$-1.58	$-1.02	$-0.98	$-0.89	$-1.03	$-1.09	$-0.97	$-0.58	$-0.74	$-1.20	$-7.32	$-0.08	$-0.16	—	$-39.58	$-0.43	$-0.38	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.14	$-1.62	—	$-1.36	—	$-1.27	—	—	—	$-1.36	—	—	—	$-1.87	—	—	—	—	—	$-0.37	$-0.37	—	—	—	—	—	—
Book Value per Share (USD)	$16.80	$18.03	$19.53	$16.38	$17.70	$19.10	$14.85	$15.73	$16.45	$13.69	—	$14.87	$16.25	$11.90	$10.15	$2.41	$2.47	$2.58	$-70.60	$3.27	$3.66	$3.98	$-1.40	—	—	—	—
Tangible Book Value per Share (USD)	$16.80	$18.03	$19.53	$16.38	$17.70	$19.10	$14.85	$15.73	$16.45	$13.69	—	$14.87	$16.25	$11.90	$10.15	$2.41	$2.47	$2.58	$-70.60	$3.27	$3.66	$3.98	$-1.40	—	—	—	—
Basic Weighted Avg Shares (shares)	38.69M	38.49M	—	35.18M	35.02M	33.32M	—	29.94M	25.65M	24.81M	—	24.32M	21.48M	18.95M	—	43.26M	43.23M	—	—	43.09M	43.04M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$702.40M	$716.31M	$767.26M	$600.42M	$640.99M	$686.86M	$470.30M	$467.68M	$487.93M	$337.10M	—	$359.85M	$372.05M	$232.16M	$175.91M	$103.20M	$106.69M	$111.39M	$77.06M	—	—	$174.83M	$-19.81M	—	—	—	—
LT Debt (USD)	$59.34M	$29.36M	$29.16M	$28.95M	$28.74M	$28.53M	$28.32M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$14.00M	—	—	—	—
Total Equity (USD)	$644.16M	$688.43M	$739.83M	$573.39M	$614.16M	$660.36M	$443.59M	$467.96M	$488.83M	$338.07M	$345.12M	$358.97M	$371.22M	$232.85M	$176.60M	$104.57M	$106.90M	$111.61M	$-64.20M	$140.86M	$157.68M	$171.16M	$-21.86M	$-8.28M	$-6.62M	$10.00K	$-10.43M

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$90.00K	$89.00K	$89.00K	$87.00K	—	$20.00K	$9.00K	—	—	$26.00K	$25.00K	—	—	$25.00K	$25.00K	$0.00	$0.00	$0.00	—	$58.00K	$62.00K	$65.00K	$87.00K	$80.00K	$78.00K	$77.00K	—
Net Income, GAAP (USD)	$-63.50M	$-63.50M	$-60.53M	$-34.09M	$-34.09M	$-34.09M	$-29.46M	$-26.95M	$-26.95M	$-26.95M	$-23.58M	$-22.78M	$-22.78M	$-22.78M	$-11.24M	$-15.23M	$-15.23M	$-15.23M	$18.08M	$-19.05M	$-19.05M	$-19.05M	$-14.31M	$-9.75M	$-9.75M	$-9.75M	—
Operating Cash Flow (USD)	$-44.20M	$-62.24M	$-43.30M	$-47.80M	—	$-41.38M	$-27.57M	—	—	$-33.60M	$-17.80M	—	—	$-35.47M	$-9.66M	—	—	$-16.34M	$19.50M	$-16.10M	$-15.93M	$-15.01M	$-8.85M	$-6.94M	$-7.03M	$-9.88M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 27 quarters

Disc Medicine, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare IRON with peers